J. Goldman & Co LP Takes $20.04 Million Position in Corteva, Inc. $CTVA

J. Goldman & Co LP acquired a new stake in shares of Corteva, Inc. (NYSE:CTVA) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 236,652 shares of the company’s stock, valued at approximately $20,042,000.

Other large investors have also bought and sold shares of the company. Hsbc Holdings PLC grew its holdings in shares of Corteva by 16.7% during the second quarter. Hsbc Holdings PLC now owns 1,479,864 shares of the company’s stock valued at $125,360,000 after buying an additional 211,386 shares during the last quarter. EFG International AG purchased a new stake in Corteva during the 2nd quarter valued at $25,000. Ancora Advisors LLC bought a new stake in shares of Corteva in the 2nd quarter worth $1,413,000. Primecap Management Co. CA bought a new position in shares of Corteva during the second quarter valued at $98,597,000. Finally, Canada Pension Plan Investment Board bought a new position in shares of Corteva during the second quarter valued at $119,346,000. 81.54% of the stock is owned by hedge funds and other institutional investors.

Corteva Stock Performance

CTVA opened at $83.18 on Wednesday. The firm has a market cap of $55.50 billion, a P/E ratio of 55.09, a PEG ratio of 2.54 and a beta of 0.57. Corteva, Inc. has a 1-year low of $60.53 and a 1-year high of $90.97. The company has a 50 day simple moving average of $82.39 and a two-hundred day simple moving average of $80.37. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10.

Corteva (NYSE:CTVA) last released its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. The firm had revenue of $6.38 billion during the quarter, compared to analyst estimates of $6.60 billion. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The business’s quarterly revenue was down 1.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Equities analysts forecast that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be given a dividend of $0.18 per share. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s payout ratio is 47.68%.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the company. Citigroup boosted their target price on Corteva from $85.00 to $86.00 and gave the stock a “neutral” rating in a research report on Monday, August 3rd. Zacks Research cut shares of Corteva from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 11th. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $101.00 price objective on shares of Corteva in a research report on Monday, August 3rd. UBS Group decreased their target price on shares of Corteva from $89.00 to $85.00 and set a “neutral” rating for the company in a research note on Tuesday, August 18th. Finally, Barclays increased their price target on Corteva from $84.00 to $91.00 and gave the company an “overweight” rating in a report on Thursday, June 11th. Fourteen investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $91.50.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.